Key result
Childhood PAH exposure linked to adverse adolescent cardiometabolic risk, particularly adiposity and dyslipidemia in girls.
Why the study?
Does childhood exposure to PAHs increase cardiometabolic risk indicators in childhood and adolescence?
Cohort (n=196)
Does childhood exposure to PAHs increase cardiometabolic risk indicators in childhood and adolescence?
Answers are grounded in this paper and cite their sources.
Childhood exposure to PAHs is associated with adverse cardiometabolic profiles in adolescence, particularly in girls.
Background Exposure to polycyclic aromatic hydrocarbons (PAHs) has been associated with cardiovascular diseases in adulthood, but studies examining childhood origins are scarce. Objective To examine associations of childhood PAH exposure with cardiometabolic risk indicators in childhood and adolescence along with differences by sex. Methods Urinary PAH metabolites [Σ1,2,3-hydroxyphenanthrene (Σ1,2,3-OH Phe), 1-hydroxypyrene (1-OH Pyr), and Σ2,3-hydroxyfluorene (Σ2,3-OH Flu)] were measured in 9-year-olds from the MINIMat cohort in Bangladesh (n = 196), using liquid chromatography with tandem mass spectrometry. Cardiometabolic indicators [lipids, C-reactive protein (CRP), insulin resistance (HOMA2 IR), blood pressure, anthropometry, and a composite cardiometabolic risk score (CMRS)] were assessed at 9 and 15 years. Associations of PAH metabolites (log 2 -transformed) with cardiometabolic indicators were assessed using multivariable-adjusted linear and logistic regression models. Results In all children, urinary 1-OH Pyr (median: 1.6 ng/mL) was positively associated with body mass index z-score at 9 and 15 years, and with triglyceride/high-density lipoprotein (HDL), cholesterol/HDL ratios, waist circumference, CMRS, and CRP at 15 years. After sex stratification, consistent associations were mainly observed in girls, especially with outcomes at age 15, where both urinary 1-OH Pyr and Σ1,2,3-OH Phe concentrations were inversely associated with HDL, and positively associated with the cholesterol/HDL ratio and CMRS. Urinary 1-OH Pyr was also positively associated with girls’ triglyceride/HDL ratio, HOMA2 IR, waist circumference, and CRP. Conclusions Our associations of childhood PAH exposure with cardiometabolic indicators in childhood and adolescence differed by sex. In girls, increased adiposity, indications of altered lipid profile and metabolic function were detected while boys seemed incongruently affected.
No takes yet. Share an insight, caveat, or question.
Trask et al. (2025) reported a cohort. Polycyclic aromatic hydrocarbons (PAHs) exposure was evaluated on Cardiometabolic indicators (lipids, CRP, HOMA2 IR, blood pressure, anthropometry, and CMRS) at 9 and 15 years. Childhood PAH exposure was positively associated with adverse cardiometabolic indicators at age 15, particularly increased adiposity and altered lipid profiles in girls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: